Michael Bromberg, MD, PhD, Chief of the Section of Hematology at Temple University Hospital, discussed with HealthCentral two newly approved gene therapies for patients with the genetic blood disorder transfusion-dependent beta thalassemia.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Moves in Medicine: Dr. Carly Fabrizio and Patient Discuss Cardiac Amyloidosis
Posted June 6, 20256abc and Temple Health collaborated on a sponsored segment about cardiac amyloidosis.
Read MoreDr. Michael Bromberg Offers Insight on Beta Thalassemia Severity to HealthCentral
Posted June 6, 2025Michael Bromberg, MD, PhD, Chief of the Section of Hematology at Temple University Hospital, explained to HealthCentral what patients need to know about Beta Thalassemia Severity.
Read More